Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Other Stockholders Equity
Equity items not reported separately, such as additional paid-in capital or treasury stock.
Teleflex IncorporatedNYSE: TFX
Other Stockholders Equity · Q2 FY2026 · quarter ended Jun 2026
Other stockholders equity remains negative
Q2 FY2026 other stockholders equity was $0, compared with $0 a year earlier.
Context
- Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Other stockholders equity increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Stockholders Equity history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Stockholders Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Stockholders Equity vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so other stockholders equity is compared through growth and share of total assets rather than absolute size.
- Other stockholders equity amounts to 0.0% of total assets for TFX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $8.61B USD | — | — | 62.1% | |
| Sep 2026 | $3.93B USD | — | — | 153.8% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | — | |
| Jun 2026 | -€1K EUR | -100.0% | — | 0.0% | |
| Peer median (excluding TFX) | — | -100.0% | — | 0.0% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 445.08M | 292.03M | 222.85M | 290.19M | 393.26M |
| Short-term Investments | 0 | 0 | 0 | 15.97M | 0 |
| Net Receivables | 383.57M | 408.83M | 443.47M | 459.5M | 345.58M |
| Inventory | 477.64M | 578.51M | 626.22M | 600.13M | 404.4M |
| Other Current Assets | 117.28M | 125.08M | 107.47M | 101.88M | 775.53M |
| Total Current Assets | 1.43B | 1.41B | 1.41B | 1.47B | 1.94B |
| Property, Plant & Equipment (Net) | 573.41M | 578.42M | 603.43M | 611.76M | 590.1M |
| Goodwill | 2.5B | 2.54B | 2.91B | 2.63B | 2.31B |
| Intangible Assets | 2.29B | 2.31B | 2.5B | 2.27B | 1.52B |
| Long-term Investments | 0 | 11.91M | 0 | 0 | 11.19M |
| Tax Assets | 6.82M | 6.4M | 6.75M | 11.37M | 12.59M |
| Other Non-current Assets | 69.1M | 77.46M | 98.94M | 102.62M | 565.82M |
| Total Non-current Assets | 5.44B | 5.52B | 6.13B | 5.63B | 5.01B |
| Total Assets | 6.87B | 6.93B | 7.53B | 7.1B | 6.95B |
| Account Payables | 118.24M | 126.81M | 132.25M | 141.03M | 130.2M |
| Short-term Debt | 110M | 87.5M | 87.5M | 100M | 100M |
| Tax Payables | 83.94M | 24.74M | 41.45M | 41.32M | 18.79M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 55.63M | 63.38M | 46.55M | 68.54M | 388.27M |
| Total Current Liabilities | 680.12M | 581.49M | 606.75M | 649.36M | 762.03M |
| Long-term Debt | 1.74B | 1.62B | 1.73B | 1.56B | 2.54B |
| Deferred Tax Liabilities | 370.12M | 388.89M | 456.08M | 391.07M | 183.75M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 210.6M | 191.26M | 189.86M | 124.32M | 251.04M |
| Total Non-current Liabilities | 2.44B | 2.32B | 2.48B | 2.17B | 3.06B |
| Total Liabilities | 3.12B | 2.91B | 3.09B | 2.82B | 3.82B |
| Common Stock | 47.93M | 47.96M | 48.05M | 48.1M | 48.2M |
| Retained Earnings | 3.52B | 3.82B | 4.11B | 4.12B | 3.15B |
| Accumulated OCI | (346.96M) | (403.52M) | (314.41M) | (316.67M) | (239.47M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3.75B | 4.02B | 4.44B | 4.28B | 3.12B |
| Total Debt | 1.97B | 1.83B | 1.93B | 1.76B | 2.73B |
| Net Debt | 1.52B | 1.54B | 1.7B | 1.46B | 2.33B |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.